Atazanavir
Atazanavir (Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents. Atazanavir is a substrate and inhibitor of cytochrome P450 isozyme 3A (CYP3A4) and an inhibitor and inducer of P-glycoprotein.
Trivial name | Latazanavir, Zrivada, Reyataz, BMS-232632 |
Catalog Number | S4662 |
Molecular Formula | C38H52N6O7 |
CAS# | 198904-31-3 |
Inchi | InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1- 8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 |
Inchi Key | AXRYRYVKAWYZBR-GASGPIRDSA-N |
SMILES | CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC |
Size | 50mg |
Supplier Page | http://www.selleckchem.com/products/atazanavir-reyataz.html |
Additional Information | https://file.selleck.cn/downloads/struct/atazanavir-chemical-structure-s4662.gif |